SEMA GLP-1

Research Overview

SEMA is a synthetic peptide investigated in metabolic research as a single GLP-1 receptor agonist. It is supplied as a lyophilized powder in independently sealed sterile vials, allowing investigators to reconstitute material at the point of use according to specific experimental requirements.

This compound is studied across metabolic research models for activity on glucose response, energy regulation, and adipose tissue research. SEMA represents the first generation of investigational GLP-1 family peptides, single-receptor compounds focused on incretin signaling. Subsequent generations expanded receptor coverage: TIRZ adds GIP for dual incretin engagement, and RETA extends further to include glucagon receptor activity. Among the three, SEMA is the most pharmacologically focused and the most extensively characterized in published research given its longer time on the research scene.

The single-receptor mechanism makes SEMA methodologically useful as a research baseline. Studies that compare multi-receptor compounds against single-receptor controls require a well-characterized GLP-1-only peptide as a reference point, which is the role SEMA most often fills in contemporary metabolic peptide research design.

For mechanism research, integrated pharmacology, and the published findings on GLP-1 receptor agonist research, see Semaglutide Research. For comparative research between SEMA and the dual-agonist TIRZ across receptor pharmacology and pre-clinical model systems, see Semaglutide vs Tirzepatide.

Mechanism

SEMA is engineered to engage the GLP-1 receptor pathway. Among the metabolic peptide family, it is distinguished as a single-agonist compound, in contrast to dual-agonist (TIRZ) and triple-agonist (RETA) compounds in the same investigational family.

The compound has been studied in peer-reviewed research for its effects on glucose homeostasis, insulin response, and energy regulation in preclinical contexts. Investigators studying GLP-1 receptor pharmacology use SEMA in research designs where a defined single-receptor control is required, including binding affinity studies, downstream signaling assays examining G-protein-coupled receptor kinetics, and comparative work against multi-receptor agonists in the same family.

Product Specifications

• Class: Single agonist research peptide (GLP-1)
• Purity: ≥99% (HPLC verified)
• Testing: HPLC + Mass Spectrometry
• Form: Lyophilized powder
• Container: Sterile vial
• Available Vial Sizes: 10mg, 30mg
• Storage: Refrigerated (2 to 8 degrees Celsius)
• Documentation: Batch-specific COA available

Reconstitution and Storage

SEMA is supplied as lyophilized powder in independently sealed sterile vials. Reconstitution is performed by adding bacteriostatic or sterile water to the vial according to the volume protocol used in the specific research application. Reconstitution volume varies by intended working concentration; investigators selecting reconstitution methodology should reference established protocols for their experimental model.

Storage of lyophilized vials at minus 20 degrees Celsius preserves primary structural integrity and biological activity for two to three years for most well-prepared research peptides. Refrigerated storage at 2 to 8 degrees Celsius is acceptable for active inventory expected to be used within months. Once reconstituted, peptides return to aqueous-phase stability constraints and should be used within the documented stability window for the specific compound rather than relying on a generic timeline.

For a detailed treatment of the freeze-drying process, storage temperatures, shelf life expectations, and quality indicators researchers use to assess lyophilized material before reconstitution, see Lyophilized Peptides: Methodology and Stability.

Quality and Verification

Every Genevium batch is independently tested by third-party laboratories. Reverse-phase HPLC confirms purity. Mass spectrometry confirms identity. Nothing ships until the compound clears a 99%+ purity threshold.

A batch-specific Certificate of Analysis is published for every order and is retrievable by batch number on the COA Lookup page. The COA documents purity by HPLC, identity by mass spectrometry, and the analytical conditions under which both were measured.

Research Applications

SEMA is studied in research contexts where investigators require a defined single-receptor GLP-1 agonist for in vitro receptor binding and signaling assays, ex vivo tissue model systems, or pre-clinical animal model research on glucose homeostasis, insulin response, and energy regulation. The single-receptor mechanism produces a clean pharmacological signature that supports both standalone GLP-1 research and comparative work against multi-receptor compounds where SEMA serves as the methodological baseline.

Frequently Asked Questions

How does SEMA differ from TIRZ and RETA?

SEMA engages a single receptor pathway: GLP-1. TIRZ engages two: GLP-1 and GIP. RETA engages three: GLP-1, GIP, and glucagon. The three compounds therefore represent successive generations of metabolic peptide research, with SEMA the most pharmacologically focused and the longest-characterized in published literature. For the full comparative research overview between SEMA and TIRZ, see Semaglutide vs Tirzepatide.

How is SEMA reconstituted for research use?

Bacteriostatic or sterile water is added to the lyophilized vial according to the volume protocol used in the specific research application. Reconstitution volume varies by intended working concentration. Investigators should reference established protocols for their experimental model rather than rely on a generic dilution.

What vial sizes are available?

SEMA is offered in three vial sizes for research applications: 10mg, 20mg, and 30mg. Each vial is supplied as lyophilized powder in an independently sealed sterile container, with batch-specific Certificate of Analysis documenting purity and identity for the lot.

How is SEMA quality verified?

Each batch is tested independently by third-party laboratories using reverse-phase HPLC for purity quantification and mass spectrometry for identity confirmation. The Certificate of Analysis is retrievable by batch number from the COA Lookup page. Genevium ships nothing below 99% HPLC purity.

For laboratory solution preparation, the reconstitution calculator determines the bacteriostatic water volume required to achieve a target concentration for a given quantity of lyophilized peptide.